{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3214, 
        3228
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3511, 
        3525
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3684, 
        3698
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3857, 
        3871
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4031, 
        4045
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4234, 
        4248
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4414, 
        4428
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4854, 
        4868
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4875, 
        4898
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2791, 
        2818
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        455, 
        484
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2302, 
        2337
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3195, 
        3203
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3492, 
        3500
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3665, 
        3673
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3838, 
        3846
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4012, 
        4020
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4215, 
        4223
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4395, 
        4403
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3204, 
        3213
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3501, 
        3510
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3674, 
        3683
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3847, 
        3856
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4021, 
        4030
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4224, 
        4233
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4404, 
        4413
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2840, 
        2850
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2951, 
        2961
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3061, 
        3070
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3171, 
        3181
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3359, 
        3369
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3469, 
        3478
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3643, 
        3652
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3816, 
        3824
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3989, 
        3998
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4193, 
        4202
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4667, 
        4677
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2820, 
        2821
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160511121429|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&&ON^^^^JHN||XXXXXXXXX^XXXXX^X||99999999|M|||999 XXXXXX XXXX XXXX^^XXXX XXXXX^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BZ00604592|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160425|||33114^XXXXXX^XXXX^^^XX.||||||||||||20160511|||F||||||||\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 12 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 13 mm and 3 fragments measuring innE\\total 6 mm in length by less than 1 mm innE\\diameter. Embedded in toto.nE\nE\\3.Specimen consists of 2 tan tissue coresnE\\measuring 8 and 9 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 15 mm and 2 fragment measuring in totalnE\\2 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\6.Specimen consists of 2 tan tissue coresnE\\measuring 6 and 8 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\nE\\7.Specimen consists of 2 tan tissue coresnE\\each measuring 7 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\nE\\8.Specimen consists of 1 tan tissue corenE\\measuring 12 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\9.Specimen consists of 1 tan tissue corenE\\measuring 9 mm and 2 fragments measuring in totalnE\\5 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 14 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 14 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\12.Specimen consists of 2 tan tissue coresnE\\measuring 5 and 8 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  7 / 12nE\\# cores involved/total cores  7 / 12nE\\Overall % tissue involved  40%nE\\% involvement in mostnE\\extensively involved core  95%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)8 (4, 4)nE\\Highest Gleason Score (any site)8 (4, 4)nE\\% Gleason patterns 4, 5  100%nE\nE\\OthernE\\Perineural invasion     PresentnE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\4.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 3% TISSUE INVOLVEMENT. ?see comment?nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\6.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 75% TISSUE INVOLVEMENT.nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 70% TISSUE INVOLVEMENT.nE\nE\\8.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 75% TISSUE INVOLVEMENT.nE\nE\\9.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 95% TISSUE INVOLVEMENT;nE\\FOCAL PERINEURAL INVASION.nE\nE\\10.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 75% TISSUE INVOLVEMENT.nE\nE\\11.BIOPSY, PROSTATE (LEFT APICAL ADDITIONAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 8/10 (PRIMARY 4, SECONDARY 4); 1/1 COREnE\\INVOLVED; 85% TISSUE INVOLVEMENT.nE\nE\\12.BIOPSY, PROSTATE (RIGHT APICALnE\\ADDITIONAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\COMMENT #4nE\nE\\In the Right Apex Lateral biopsy, immunostainsnE\\for P63 and HMWK are negative in thenE\\adenocarcinoma and stain positively in the non-nE\\tumorous glands and AMACR is positive in thenE\\focus of adenocarcinoma.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 31.66 ng/mLnE\\5ARI Therapy (past 6 months): NonE\\DRE Findings:  Suspect T2nE\\Location: LeftnE\\Volume (cc):  27.5nE\\TRUS Findings:  Left peripheral zonenE\nE\\Family History: Positive, Dad and UnclenE\\Other: PSAD = 1.15nE\nE\\Date and Time Placed in Formalin (NBF):nE\\2016/04/21 @ 16:00 hoursnE\\\n\n\n"
}